US78423T2006 - SHLT (XNAS)
SHL Telemedicine Ltd - American Depositary Shares Hinterlegungsschein
3,70 USD
Aktuelle Kurse von SHL Telemedicine Ltd - American Depositary Shares
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
SHLT
|
USD
|
19.09.2024 21:53
|
3,70 USD
| 3,75 USD | -1,33 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -3,65 % | -3,39 % | -30,06 % | -40,61 % | -64,18 % | -74,67 % |
Firmenprofil zu SHL Telemedicine Ltd - American Depositary Shares Hinterlegungsschein
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.
Unternehmensdaten SHL Telemedicine Ltd - American Depositary Shares Hinterlegungsschein
Name SHL Telemedicine Ltd - American Depositary Shares
Firma SHL Telemedicine Ltd.
Symbol SHLT
Website https://www.shl-telemedicine.com
Heimatbörse
NASDAQ
ISIN US78423T2006
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Medical - Healthcare Information Services
CEO Mr. David Arnon
Marktkapitalisierung 63 Mio
Land Israel
Währung USD
Mitarbeiter 0,6 T
Adresse Ashdar Building, 67891 Tel Aviv
IPO Datum 2023-04-03
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | SHLT |
Weitere Aktien
Investoren die SHL Telemedicine Ltd - American Depositary Shares halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024